KIM PHAN: Open Payments
NPI 1043934706 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 54 payments from 16 companies in 2025. Trend: 2023 $1,499 · 2024 $1,590 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $283 |
| Incyte Corporation | 9 | $185 |
| PFIZER INC. | 10 | $158 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $72 |
| GENZYME CORPORATION | 2 | $55 |
| Almirall LLC | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| UCB, Inc. | 1 | $25 |
| REVANCE THERAPEUTICS, INC. | 1 | $24 |
| LNHC, Inc | 1 | $24 |
Products named: OPZELURA, CIBINQO, BOTOX, SKYRIZI, ILUMYA, RINVOQ, DUPIXENT, Klisyri.
Industry payments across CA — which companies pay providers there.
